Dr. Traverso earned his medical degree from the University of Cambridge in the United Kingdom and completed his residency at Brigham and Women’s Hospital. He also completed a fellowship in gastroenterology at Harvard Medical School in Boston.
Dr. Traverso’s previous work focused on the development of novel molecular tests for the early detection of colon cancer. His research has been published in the New England Journal of Medicine, The Lancelet, Nature Biotechnology and Cancer Research. He is the recipient of the grand prize of the Collegiate Inventors Competition, a research fellowship from Trinity College in Hartford, Conn., and was named one of the most promising innovators under 35 by the MIT Tech Review’s TR 35.
Dr. Traverso’s current work is focused on the development of novel technologies for drug delivery through the gastrointestinal tract.
More articles on GI & endoscopy:
Medtronic’s PillCam COLON 2 approved for expanded indication, FTC asks for more information on Pfizer-Allergan merger — 6 GI company key notes
Texas Children’s Hospital names Dr. Tamir Miloh pediatric hepatology, liver transplant director: 5 things to know
New 3D version of imaging offers enhanced detection of advanced liver fibrosis: 5 insights
